Abstract:The field of infectious disease diagnostics is burdened by inequality in access to healthcare resources. In particular, "point-of-care" (POC) diagnostics that can be utilized in non-laboratory, sub-optimal environments are appealing for disease control with limited resources. Electrochemical biosensors, which combine biorecognition elements with electrochemical readout to enable sensitive and specific sensing using inexpensive, simple equipment, are a major area of research for the development of POC diagnostics. To improve the limit of detection (LOD) and selectivity, signal amplification strategies have been applied towards these sensors. In this perspective, we review recent advances in electrochemical biosensor signal amplification strategies for infectious disease diagnostics, specifically biosensors for nucleic acids and pathogenic microbes. We classify these strategies into target-based amplification and signal-based amplification. Target-based amplification strategies improve the LOD by increasing the number of detectable analytes, while signal-based amplification strategies increase the detectable signal by modifying the transducer system and keep the number of targets static. Finally, we argue that signal amplification strategies should be designed with application location and disease target in mind, and that the resources required to produce and operate the sensor should reflect its proposed application, especially when the platform is designed to be utilized in low-resource settings. We anticipate that, based on current technologies to diagnose infectious diseases, incorporating signal-based amplification strategies will enable electrochemical POC devices to be deployed for illnesses in a wide variety of settings.

Improving electrochemical hybridization assays with restriction enzymes

Nucleic acid-based electrochemical nanobiosensors.

Electrochemical Biosensors Combined with Isothermal Amplification for Quantitative Detection of Nucleic Acids.

Hybridization Chain Reaction-Based Electrochemical Biosensors by Integrating the Advantages of Homogeneous Reaction and Heterogeneous Detection

Electrochemical nucleic acid sensors: Competent pathways for mobile molecular diagnostics

Electrochemical Biosensors Employing Hybridization Chain Reaction: From Structural Design to Applications

A novel electrochemical biosensor based on dynamic polymerase-extending hybridization for E. coli O157:H7 DNA detection.

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

An ultrafast ratiometric electrochemical biosensor based on potential-assisted hybridization for nucleic acids detection

Label-free, Background-Free Detection of Nucleic Acid with Immobilization-Free Heterogeneous Biosensor and One-Pot Hybridization Chain Reaction Amplification

Application of Hybridization Chain Reaction (HCR) in Electrochemical Analysis

Electrochemical DNAzyme-based biosensors for disease diagnosis

Affinity-based electrochemical sensors for biomolecular detection in whole blood

Hybridization Chain Reaction-Amplified Electrochemical DNA-Based Sensors Enable Calibration-Free Measurements of Nucleic Acids Directly in Whole Blood

Electrochemical biosensors for DNA analysis.

Recent Advances in Signal Amplification to Improve Electrochemical Biosensing for Infectious Diseases

CRISPR-based electrochemical biosensors: an alternative for point-of-care diagnostics?

Point-of-care Biochemical Assays Using Electrochemical Technologies: Approaches, Applications, and Opportunities.

Development of Nucleic Acid-based Electrochemical Biosensors for Clinical Applications.

Advancements in Biosensors for Point-of-Care Testing of Nucleic Acid

DNA Nanomaterial-Based Electrochemical Biosensors for Clinical Diagnosis